1. Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Issue 5 (May 2021) Authors: Biemond, Bart J; Tombak, Anil; Kilinc, Yurdanur; Al-Khabori, Murtadha; Abboud, Miguel; Nafea, Mohammed; Inati, Adlette; Wali, Yasser; Kristensen, Jens; Kowalski, Jan; Donnelly, Ellen; Ohd, John; Nur, Erfan; Rijneveld, Anita W.; Antmen, Alibülent; Reid, Marvin; Ukala, Gabriel; Kirven-Dawes, Lisa; ... Journal: Lancet Issue: Volume 8:Issue 5(2021) Page Start: e334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗